|SRX -- Australia Stock|| |
AUD 33.55 0.00 0.00%
Mr. Gilman Wong was Chief Executive Officer Managing Director and Executive Director of the Company. Mr Wong was appointed Chief Executive Officer in May 2005 and director in June 2005. Mr Wong previously held CEO and senior executive positions in various industries. He has a strong planning and sales and marketing background.
Age: 65 CEO Since 2014
61 2 9964 8400 http://www.sirtex.com
Wong previously held CEO and senior executive positions in the commercial and industry sector including 10 years with Email Limited. He has planning and sales and marketing background.
The company has return on total asset (ROA)
of 17.25 %
which means that it generated profit of $17.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 26.87 %
meaning that it generated $26.87 on every $100 dollars invested by stockholders.
Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. As of September 20, 2018, Sirtex Medical Limited operates as a subsidiary of CDH Genetech Limited. Sirtex Medical operates under Biotechnology classification in Australia and is traded on Australian Securities Exchange.Sirtex Medical Limited (SRX) is traded on Australian Securities Exchange in Australia and employs 292 people.
Sirtex Medical Leadership Team
|Darren Smith, CFO, Company Secretary|
|Richard Hill, Non-Executive Chairman of the Board|
|Neville Mitchell, Independent Non-Executive Director|
|Gilman Wong, CEO, Managing Director and Executive Director|
|Tom Duthy, Global Investor Relations Manager|
|Michael Mangano, President of Americas Region|
|Katherine Woodthorpe, Non-Executive Independent Director|
|Nigel Lange, CEO of Europe|
|John Eady, Non-Executive Deputy Chairman of the Board|
|Anthony Dixon, Executive Vice President of Sales and Marketing,EMEA|
|Robert Hardie, Global Head of Operations|
|Helen Kurincic, Independent Non-Executive Director|
|Kevin Richardson, CEO, Americas|
|Rueben Teo, CEO, Asia Pacific (APAC)|
|David Cade, Global Medical Director|
|Andrew McLean, CEO, Executive Director|
|Grant Boyce, Non-Executive Director|
Stock Performance Indicators
Most of Macroaxis users are at this time bullish on Sirtex Medical Limited. What is your outlook on investing in Sirtex Medical Limited? Are you bullish or bearish?
Currently Active Assets on Macroaxis